Marissa Robinson, DrPH, MPH, is an Ending the HIV Epidemic Coordinator, The Department of Health and Human Services, Washington, District of Columbia, USA.
Gloria Aidoo-Frimpong, PhD, MPH, MA, is a Postdoctoral Fellow, Center for Interdisciplinary Research on AIDS, Yale AIDS Prevention Program, Yale School of Public Health, New Haven, Connecticut, USA.
J Assoc Nurses AIDS Care. 2024;35(3):234-244. doi: 10.1097/JNC.0000000000000470.
Black women are essential to ending the HIV epidemic in the United States; yet prevention, access, testing, and structural racism affect how HIV disproportionately affects them. Limited public health research focuses on Black women attending Historically Black Colleges and Universities (HBCUs) and the ability to address HIV prevention, such as pre-exposure prophylaxis (PrEP) uptake. PrEP is a once-daily oral pill used to prevent HIV transmission and has suboptimal uptake within the Black community. This generic qualitative descriptive analysis identifies the barriers and facilitators of PrEP uptake among Black women attending an HBCU using the health belief model. Overall, 22 Black college women participated in a 60-minute focus group. Emergent categories were as follows: (a) Barriers-stigma, cost, and side effects; (b) Facilitators-PrEP's effectiveness, exposure to HIV, and unprotected sex. Our findings can inform future efforts to increase PrEP uptake among Black women attending an HBCU.
黑人女性对于终结美国的艾滋病毒流行至关重要;然而,预防措施、可及性、检测以及结构性种族主义影响了艾滋病毒对她们的不成比例的影响。有限的公共卫生研究关注的是在历史上的黑人学院和大学(HBCUs)就读的黑人女性,以及解决艾滋病毒预防问题的能力,例如暴露前预防(PrEP)的采用率。PrEP 是一种每日一次的口服药物,用于预防艾滋病毒传播,但其在黑人社区的采用率并不理想。本研究采用健康信念模型,对在 HBCU 就读的黑人女性采用 PrEP 的障碍和促进因素进行了定性描述分析。共有 22 名黑人女大学生参加了 60 分钟的焦点小组。出现的类别如下:(a)障碍-耻辱感、费用和副作用;(b)促进因素-PrEP 的有效性、接触艾滋病毒和无保护性行为。我们的研究结果可以为未来在 HBCU 就读的黑人女性中增加 PrEP 的采用率提供信息。